
OPKO Health OPK
€ 1.00
0.86%
Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025
OPKO Health DSO 2011-2026 | OPK
DSO Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 240 | 252 | 70.3 | 56.1 | 53.5 | 63.8 | 59.7 | 64 | 74.5 | 155 | 92.3 | 119 | 183 | 164 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 252 | 53.5 | 118 |
DSO Vierteljährlich OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.9 | 61.7 | 55.7 | 54.3 | 60.1 | 83.9 | 57.1 | 47.8 | - | 31.3 | 31.3 | 65.5 | 58.5 | 61.6 | 60.5 | 50.8 | 52.8 | 61 | 86.7 | 90.8 | 54.8 | 53.7 | 54.3 | 57.1 | 59.2 | 52.6 | 49.8 | 55.4 | 93.8 | 61.4 | 51.6 | 66.1 | 81.4 | 67.4 | 56.3 | 64.9 | 64 | 124 | 417 | 324 | 71.4 | 92.2 | 77.4 | 81.4 | 87.2 | 87.4 | 75.7 | 59.5 | 119 | 164 | 189 | 175 | 198 | 168 | 136 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 417 | 31.3 | 89.2 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
63.8 | $ 117.5 | 2.1 % | $ 35.7 B | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 16.83 | 4.86 % | $ 897 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 1.45 | 5.84 % | $ 1.93 M | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 23.53 | 1.73 % | $ 654 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 178.34 | 1.53 % | $ 8.84 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.59 | 5.52 % | $ 425 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 501.23 | 1.56 % | $ 14.5 B | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.0 | 4.03 % | $ 1.02 B | ||
|
Danaher Corporation
DHR
|
55.3 | $ 195.87 | 3.3 % | $ 140 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
61.3 | $ 126.96 | 4.99 % | $ 20.2 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.3 | 6.03 % | $ 463 M | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 6.72 | 0.6 % | $ 280 M | ||
|
Guardant Health
GH
|
46.1 | $ 82.21 | 4.59 % | $ 10.3 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.85 | 5.95 % | $ 92.5 K | ||
|
Biomerica
BMRA
|
57.7 | $ 2.08 | -2.8 % | $ 4.78 M | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 110.37 | 3.33 % | $ 9.1 B | ||
|
Soleno Therapeutics
SLNO
|
27 | $ 52.64 | 0.02 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 264.18 | 1.25 % | $ 22 B | ||
|
Natera
NTRA
|
81.5 | $ 201.9 | 4.6 % | $ 19.9 B | ||
|
Neuronetics
STIM
|
48.7 | $ 1.39 | 2.96 % | $ 91.7 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 81.67 | 1.34 % | $ 5.51 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 192.91 | 0.73 % | $ 21.4 B | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.14 | -2.97 % | $ 1.98 B | ||
|
ENDRA Life Sciences
NDRA
|
7.11 | $ 5.19 | 5.06 % | $ 4.08 M | ||
|
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M |